ASX
Cynata Therapeutics Limited
CYP:ASX•Healthcare
Sensitive ASX Announcement
Positive 6-Month Data from Cohort 1 in Phase 1 Trial in GvHD
Published: 12/06/18, 09:31am (AEST)•2 pages